Versatile & Convenient Administered via injections, capsules, dissolvable tablets, or nasal sprays
Every patient should be evaluated individually by a qualified healthcare provider
Absence of clinical safety data No Phase 1 clinical safety trial for BPC-157 has been completed and published
A qualified clinician assesses you, selects the right needle and route, and gives the injection using single-use equipment and a clean technique, so it is quick, comfortable and safe
There is also a risk that prolonged use of BPC 157 could lead to severe health consequences, including the possibility of tumors or effects on fertility
However, recovery pathways are not the same as guaranteed recovery outcomes